Esperion Therapeutics, Inc. (ESPR)

Jul 13, 2026 - ESPR was delisted

3.180

-0.010 (-0.31%)

Inactive · Last trade price on Jul 10, 2026

Esperion Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	819	907	431	353	465	304
Market Cap Growth	305.27%	110.57%	21.91%	-23.92%	52.62%	-54.83%
Enterprise Value	1,207	991.68	583.72	537.37	558.66	305.26
Last Close Price	3.18	3.70	2.20	2.99	6.23	5.00

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	12.26	16.60	-	-	-
PS Ratio	1.96	2.25	1.30	3.04	6.16	3.88
PB Ratio	-	-3.00	-1.11	-0.78	-1.43	-1.55

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.89	2.46	1.76	4.62	7.40	3.89
EV/EBITDA Ratio	15.91	16.42	10.72	-	-	-
EV/EBIT Ratio	15.93	16.45	10.73	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-0.81	-0.83	-0.76	-0.58	-0.80	-1.31
Debt / EBITDA Ratio	3.33	4.18	5.46	-	-	-
Net Debt / Equity Ratio	-0.31	-0.28	-0.39	-0.40	-0.29	0.00
Net Debt / EBITDA Ratio	1.27	1.40	2.81	-1.18	-0.53	0.00
Net Debt / FCF Ratio	-5.25	-6.44	-6.38	-1.36	-0.54	0.00
Asset Turnover	0.90	1.00	1.21	0.51	0.24	0.21
Inventory Turnover	1.26	1.29	0.86	0.86	0.77	0.56
Quick Ratio	0.96	1.02	0.91	0.84	2.17	3.85
Current Ratio	1.53	1.54	1.37	1.29	2.67	4.48
Return on Equity (ROE)	1.83%	6.57%	12.27%	53.74%	89.74%	183.64%
Return on Assets (ROA)	16.33%	16.20%	19.80%	-68.57%	-57.03%	-61.71%
Return on Invested Capital (ROIC)	46.32%	49.95%	73.94%	-151.62%	-77.39%	-79.92%
Return on Capital Employed (ROCE)	46.32%	45.89%	73.94%	-151.62%	-77.39%	-79.92%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Buyback Yield / Dilution	-14.32%	-11.05%	-81.54%	-55.26%	-129.76%	-5.20%
Total Shareholder Return	-14.32%	-11.05%	-81.54%	-55.26%	-129.76%	-5.20%

SEC Filings: 10-K · 10-Q